Belite Bio BLTE
NASDAQ BLTE
$155.94 -0.58 (-0.37%)
At close: Nov 11, 2026 · 4:00 PM EST

Belite Bio (BLTE) Share-based Compensation (2024 - 2025)

Updated

Belite Bio (BLTE) posted Share-based Compensation of $11.71 million for Q4 2025, up 178.6% from $4.21 million a year earlier.

Analysis

Belite Bio (BLTE) Share-based Compensation (2024 - 2025) Analysis & Trends

For FY2025, Belite Bio's Share-based Compensation came in at $38.92 million, up 333.1% from FY2024.

  • Annual Share-based Compensation has increased for three consecutive years, with a five-year compound annual growth rate of 95.5% (FY2020 to FY2025).
  • In prior years, Belite Bio's Share-based Compensation was $8.99 million in FY2024 (+135.1%), $3.82 million in FY2023 (+157.8%), $1.48 million in FY2022 (-3.1%) and $1.53 million in FY2021 (+12.3%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 357.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 160.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 234.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 362.00 Mn
10 Belite Bio 6.16 Bn 6.16 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 11.71 Mn
Dec 31, 2024 4.21 Mn
API Access

Belite Bio Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BLTE&period=max&api_key=YOUR_API_KEY